RYTM logo

Rhythm Pharmaceuticals (RYTM) Company Overview

Profile

Full Name:

Rhythm Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 9, 2017

Indexes:

Not included

Description:

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic agents for the treatment of rare genetic disorders characterized by severe obesity and unrelenting hunger or hyperphagia. The company was founded in 2013 in Boston, Massachusetts. The company's research is dedicated to studying rare genetic obesity disorders caused by a disruption in the pathway in the brain known as the melanocortin-4 receptor (MC4R) pathway. The company produces an MC4R agonist - setmelanotide, the use of which may serve as a replacement therapy for the treatment of MC4R pathway deficiency. The company also has a number of drugs in early stages of research. Currently, the company does not have any approved drugs.

Key Details

Price

$52.40

Annual Revenue

$130.13 M(+68.06% YoY)

Annual EPS

-$4.34(-35.62% YoY)

Annual ROE

-155.91%

Beta

1.42

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 27, 25 Needham
Buy
Feb 27, 25 Canaccord Genuity
Buy
Feb 24, 25 Needham
Buy
Feb 19, 25 Needham
Buy
Dec 23, 24 JMP Securities
Market Outperform
Dec 23, 24 HC Wainwright & Co.
Buy
Dec 20, 24 Oppenheimer
Outperform
Dec 5, 24 Goldman Sachs
Buy
Dec 4, 24 HC Wainwright & Co.
Buy
Nov 25, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Rhythm Pharmaceuticals?
  • Does Rhythm Pharmaceuticals pay dividends?
  • What sector is Rhythm Pharmaceuticals in?
  • What industry is Rhythm Pharmaceuticals in?
  • What country is Rhythm Pharmaceuticals based in?
  • When did Rhythm Pharmaceuticals go public?
  • Is Rhythm Pharmaceuticals in the S&P 500?
  • Is Rhythm Pharmaceuticals in the NASDAQ 100?
  • Is Rhythm Pharmaceuticals in the Dow Jones?
  • When was Rhythm Pharmaceuticals's last earnings report?
  • When does Rhythm Pharmaceuticals report earnings?
  • Should I buy Rhythm Pharmaceuticals stock now?

What is the ticker symbol for Rhythm Pharmaceuticals?

The ticker symbol for Rhythm Pharmaceuticals is NASDAQ:RYTM

Does Rhythm Pharmaceuticals pay dividends?

No, Rhythm Pharmaceuticals does not pay dividends

What sector is Rhythm Pharmaceuticals in?

Rhythm Pharmaceuticals is in the Healthcare sector

What industry is Rhythm Pharmaceuticals in?

Rhythm Pharmaceuticals is in the Biotechnology industry

What country is Rhythm Pharmaceuticals based in?

Rhythm Pharmaceuticals is headquartered in United States

When did Rhythm Pharmaceuticals go public?

Rhythm Pharmaceuticals's initial public offering (IPO) was on October 9, 2017

Is Rhythm Pharmaceuticals in the S&P 500?

No, Rhythm Pharmaceuticals is not included in the S&P 500 index

Is Rhythm Pharmaceuticals in the NASDAQ 100?

No, Rhythm Pharmaceuticals is not included in the NASDAQ 100 index

Is Rhythm Pharmaceuticals in the Dow Jones?

No, Rhythm Pharmaceuticals is not included in the Dow Jones index

When was Rhythm Pharmaceuticals's last earnings report?

Rhythm Pharmaceuticals's most recent earnings report was on Feb 26, 2025

When does Rhythm Pharmaceuticals report earnings?

The next expected earnings date for Rhythm Pharmaceuticals is May 7, 2025

Should I buy Rhythm Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions